Cancer research is key to mitigating the sufferings caused by cancer and also to providing potential cures for some patients. Several advances have been accomplished to that end, especially with the developments of cancer immunotherapy strategy which have galvanised its role as the fourth pillar of cancer treatment (beyond surgery, radiation and chemotherapy). At the same time, technological advances have enabled clinicians to dive deep into cancer cell biology at the single cell level, and deepened our understanding of the cancer cell, cancer microenvironment, and cancer-host interactions.

Mr Ho Swee Huat

Mr Ho Swee Huat is the Founder and Managing Director of Abacus Assets Advisors Pte Ltd. Before starting the company, he had an established career in the banking industry, with 20 years of experience in Singapore, Hong Kong and New York.

He was an Independent Director and Chairman of the Audit Committee of CapitaCommercial Trust Management LTD from 2004 to 2013.

He is the current Chairman of Autism Association (Singapore) which he co-founded with a group of parents in 1992. He is also Vice-Chairman of Eden School, a special school for children with autism.

Mr Ho holds a Master’s degree from the London School of Economics and Political Science, and a Liberal Arts degree in Economics from Hamilton College, USA.

He has been a member of the Board of the Foundation since its incorporation.